Preoperative weight loss greater than 10% and operative time more than 6 hours also increased the risk.
Researchers found similar post-surgical outcomes between bladder cancer patients having primary and salvage radical cystectomy.
A prolonged hospital stay and discharge to a nursing facility were among the risks.
During a median of 6.5 years of follow-up, none of the 9 cases of bladder cancer diagnosed among 925 patients was muscle invasive.
NBI was superior at detecting early bladder tumors and carcinoma in situ, compared with WLI cystoscopy.
80% of lung cancer deaths linked to smoking, researchers say.
Researchers found no association between diabetes and urinary bladder cancer risk and mortality.
Two-thirds of patients feel that tumor profiling could improve their treatment; many will pay out of pocket.
Less than half of primary care providers refer patients with any degree of hematuria for urological evaluation.
The test displayed an overall high sensitivity for detecting bladder tumors.
Men at high-risk of bladder cancer were the most likely to be referred to urologists.
Researchers find rates lower than those observed in most clinical trials.
Screened patients were more likely to die from other smoking-related malignancies.
Levels of CEA and CA 19-9 were significantly higher in patients with tumor recurrence and/or progression.
Greater effects were seen in women with UTI, according to researchers.
Patients who experienced recurrence had a higher ratio than those who did not.
Use of the medications was associated with a significant 39% decreased risk of tumor recurrence after surgery.
Men who reported having severe lower urinary tract symptoms (LUTS) had a 64% increased risk of the malignancy compared with those who reported no LUTS.
Research raises concern about the simultaneous use of chemotherapy and fish oil.
For every 5 kg/m2 increase in BMI, the risk of bladder cancer rose 4.2%.
Daniel Canter, M.D., discusses narrow-band imaging (NBI) for visualization of bladder cancer.
Adjuvant chemotherapy is associated with better survival among patients with advanced nonmetastatic bladder cancer.
It has implications for treatment decisions and prognosis.
In a phase 2 trial, 72% of patients with high-grade clinical nonmuscle-invasive bladder cancer had a complete response at 3 months.
Researchers found elevated familial risks for testicular, prostate, bladder, and kidney cancers.
Risk factors include male gender, distant disease, increasing age, race/ethnicity
In a Canadian study, long wait times before a first urologist visit was associated with a 29% higher risk of death after radical cystectomy.
Smoking pot decreased the likelihood of the malignancy by 45%, whereas smoking tobacco only increased the likelihood by 52%.
- Complications More Likely After Radiotherapy vs. Surgery for PCa
- Metformin Use in Advanced CKD Raises Death Risk
- Heparin-Lidocaine Combo Relieves Interstitial Cystitis Symptoms
- Cholecalciferol May Be Superior for Treating Vitamin D Deficiency
- Laparoscopically Harvesting Right Kidneys from Living Donors Safe
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)